Brain Access of Monoclonal Antibodies as Imaged and Quantified by 89Zr-Antibody PET: Perspectives for Treatment of Brain Diseases

Sophie E.M. Veldhuijzen van Zanten; Philip C. De Witt Hamer; Guus A.M.S. van Dongen

doi:10.2967/jnumed.118.220939

Research ArticleOncology

Brain Access of Monoclonal Antibodies as Imaged and Quantified by ⁸⁹Zr-Antibody PET: Perspectives for Treatment of Brain Diseases

Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer and Guus A.M.S. van Dongen

Journal of Nuclear Medicine May 2019, 60 (5) 615-616; DOI: https://doi.org/10.2967/jnumed.118.220939

Sophie E.M. Veldhuijzen van Zanten

1Department of Pediatrics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

2Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philip C. De Witt Hamer

3Department of Neurosurgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guus A.M.S. van Dongen

4Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

Article Information

vol. 60 no. 5 615-616

DOI

https://doi.org/10.2967/jnumed.118.220939

PubMed

30737301

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication November 29, 2018
Accepted for publication January 13, 2019
Published online May 1, 2019.

Article Versions

previous version (February 8, 2019 - 14:40).
You are viewing the most recent version of this article.

Author Information

Statistics from Altmetric.com

Cited By...

12 Citations
10 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis

Haritha L. Desu, Melanie Plastini, Placido Illiano, Helen M. Bramlett, W. Dalton Dietrich, Juan Pablo de Rivero Vaccari, Roberta Brambilla, Robert W. Keane

Journal of Neuroinflammation 2020 17 1
The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals

Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis van Kuijk, Ronald Boellaard, Marc C. Huisman, Danielle J. Vugts

Journal of Nuclear Medicine 2021 62 4
The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors

Ilanah J. Pruis, Guus A. M. S. van Dongen, Sophie E. M. Veldhuijzen van Zanten

International Journal of Molecular Sciences 2020 21 3
Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review

Sajjad Muhammad, Shafqat Rasul Chaudhry, Ulf Dietrich Kahlert, Martin Lehecka, Miikka Korja, Mika Niemelä, Daniel Hänggi

International Journal of Molecular Sciences 2020 21 8
Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review

Volkmar Müller, Rupert Bartsch, Nancy U. Lin, Filippo Montemurro, Mark D. Pegram, Sara M. Tolaney

Cancer Treatment Reviews 2023 115
Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice

Marion Chomet, Maxime Schreurs, Ricardo Vos, Mariska Verlaan, Esther J. Kooijman, Alex J. Poot, Ronald Boellaard, Albert D. Windhorst, Guus AMS van Dongen, Danielle J. Vugts, Marc C. Huisman, Wissam Beaino

EJNMMI Research 2021 11 1
Biodistribution Analysis of an Anti-EGFR Antibody in the Rat Brain: Validation of CSF Microcirculation as a Viable Pathway to Circumvent the Blood-Brain Barrier for Drug Delivery

Ghazal Naseri Kouzehgarani, Pankaj Kumar, Susan E. Bolin, Edward B. Reilly, Didier R. Lefebvre

Pharmaceutics 2022 14 7
The blood-brain barrier limits the therapeutic efficacy of antibody-drug conjugates in glioblastoma

Roger Abounader, David Schiff

Neuro-Oncology 2021 23 12
Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [68Ga]DOTATATE

Sophie E. M. Veldhuijzen van Zanten, Eelke M. Bos, Frederik A. Verburg, Pieter-Jan van Doormaal

European Journal of Nuclear Medicine and Molecular Imaging 2021 48 5
Investigation of the Impact of the H310A FcRn Region Mutation on 89Zr-Immuno-PET Brain Imaging with a BBB-Shuttle Anti‑Amyloid Beta Antibody

Thomas E. Wuensche, Natascha Stergiou, Iris Mes, Mariska Verlaan, Esther J. M. Kooijman, Albert D. Windhorst, Allan Jensen, Ayodeji A. Asuni, Benny Bang-Andersen, Guus A. M. S. van Dongen, Danielle J. Vugts, Wissam Beaino

Molecular Imaging and Biology 2024 26 5

Article usage

Article usage: February 2019 to December 2024

	Abstract	Full	Pdf
Feb 2019	3	0	56
Mar 2019	0	0	17
Apr 2019	0	0	11
May 2019	36	153	99
Jun 2019	0	64	64
Jul 2019	0	39	33
Aug 2019	0	22	28
Sep 2019	0	27	20
Oct 2019	0	57	25
Nov 2019	0	25	14
Dec 2019	0	27	13
Jan 2020	0	63	21
Feb 2020	0	40	14
Mar 2020	0	39	21
Apr 2020	0	41	12
May 2020	0	47	27
Jun 2020	0	69	23
Jul 2020	0	17	17
Aug 2020	0	36	15
Sep 2020	0	29	13
Oct 2020	0	31	7
Nov 2020	0	29	9
Dec 2020	0	35	5
Jan 2021	0	40	11
Feb 2021	0	44	20
Mar 2021	0	44	18
Apr 2021	0	68	12
May 2021	0	51	26
Jun 2021	0	56	19
Jul 2021	0	28	16
Aug 2021	0	41	23
Sep 2021	0	28	10
Oct 2021	0	55	32
Nov 2021	0	35	27
Dec 2021	0	47	27
Jan 2022	0	26	9
Feb 2022	0	27	7
Mar 2022	0	39	12
Apr 2022	0	26	13
May 2022	0	29	19
Jun 2022	0	33	16
Jul 2022	0	25	9
Aug 2022	0	24	16
Sep 2022	0	18	11
Oct 2022	0	21	19
Nov 2022	0	30	21
Dec 2022	0	26	8
Jan 2023	0	36	9
Feb 2023	0	23	5
Mar 2023	0	27	11
Apr 2023	0	34	15
May 2023	0	20	8
Jun 2023	0	17	3
Jul 2023	0	15	10
Aug 2023	0	14	7
Sep 2023	0	12	5
Oct 2023	0	6	1
Nov 2023	0	33	13
Dec 2023	0	18	2
Jan 2024	0	13	4
Feb 2024	0	19	10
Mar 2024	0	20	49
Apr 2024	0	19	12
May 2024	0	40	7
Jun 2024	0	32	13
Jul 2024	0	12	10
Aug 2024	0	32	12
Sep 2024	0	20	13
Oct 2024	0	28	14
Nov 2024	0	22	3
Dec 2024	0	22	3

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 5

May 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Brain Access of Monoclonal Antibodies as Imaged and Quantified by 89Zr-Antibody PET: Perspectives for Treatment of Brain Diseases

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Brain Access of Monoclonal Antibodies as Imaged and Quantified by ⁸⁹Zr-Antibody PET: Perspectives for Treatment of Brain Diseases

Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer, Guus A.M.S. van Dongen

Journal of Nuclear Medicine May 2019, 60 (5) 615-616; DOI: 10.2967/jnumed.118.220939

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Brain Access of Monoclonal Antibodies as Imaged and Quantified by ⁸⁹Zr-Antibody PET: Perspectives for Treatment of Brain Diseases

Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer, Guus A.M.S. van Dongen

Journal of Nuclear Medicine May 2019, 60 (5) 615-616; DOI: 10.2967/jnumed.118.220939

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

A Distinct Advantage to Intraarterial Delivery of ⁸⁹Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood–Brain Barrier
This Month in JNM

PubMed
Google Scholar

Cited By...

The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals

Google Scholar

Oncology

Radionuclides used in Nuclear Therapeutic Medicine: a brief history, properties and main relevant studies of radionuclides with mass number less than 100
Can SPECT/CT lymphoscintigraphy help predict if a sentinel node is malignant in patients with melanoma?
Radioimmunotherapy in Oncology

Show more Oncology

Basic

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression

Show more Basic

Main menu

User menu

Search

Brain Access of Monoclonal Antibodies as Imaged and Quantified by ⁸⁹Zr-Antibody PET: Perspectives for Treatment of Brain Diseases

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: February 2019 to December 2024

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology

Basic

Similar Articles